Claro Advisors LLC Abbott Laboratories Transaction History

Claro Advisors LLC

  • $998 Million
  • Q3 2024

A detailed history of Claro Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Claro Advisors LLC holds 2,500 shares of ABT stock, worth $283,500. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,500
Previous 8,128 69.24%
Holding current value
$283,500
Previous $844,000 66.23%
% of portfolio
0.03%
Previous 0.14%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024
SELL
$100.73 - $112.44 $41,903 - $46,775
-416 Reduced 4.87%
8,128 $844,000
Q1 2024

Apr 18, 2024
BUY
$109.52 - $120.96 $32,527 - $35,925
297 Added 3.6%
8,544 $971,000
Q4 2023

Jan 22, 2024
BUY
$90.19 - $110.4 $68,995 - $84,456
765 Added 10.22%
8,247 $907,000
Q3 2023

Oct 10, 2023
BUY
$95.53 - $114.62 $297,480 - $356,926
3,114 Added 71.29%
7,482 $724,000
Q2 2023

Aug 08, 2023
SELL
$100.78 - $112.29 $111,865 - $124,641
-1,110 Reduced 20.26%
4,368 $476,000
Q1 2023

Apr 17, 2023
BUY
$96.86 - $114.01 $10,267 - $12,085
106 Added 1.97%
5,478 $554,000
Q4 2022

Feb 14, 2023
BUY
$95.06 - $111.52 $133,939 - $157,131
1,409 Added 35.55%
5,372 $589,000
Q2 2022

Aug 12, 2022
BUY
$102.07 - $123.37 $81,145 - $98,079
795 Added 25.09%
3,963 $431,000
Q4 2021

Feb 14, 2022
BUY
$115.53 - $141.46 $21,257 - $26,028
184 Added 6.17%
3,168 $446,000
Q3 2021

Nov 15, 2021
BUY
$116.66 - $129.06 $15,165 - $16,777
130 Added 4.56%
2,984 $353,000
Q2 2021

Aug 13, 2021
BUY
$105.79 - $124.53 $1,798 - $2,117
17 Added 0.6%
2,854 $331,000
Q1 2021

May 17, 2021
SELL
$108.84 - $128.23 $9,795 - $11,540
-90 Reduced 3.07%
2,837 $340,000
Q4 2020

Feb 12, 2021
SELL
$105.0 - $114.42 $73,500 - $80,094
-700 Reduced 19.3%
2,927 $321,000
Q3 2020

Nov 16, 2020
SELL
$91.64 - $111.29 $19,610 - $23,816
-214 Reduced 5.57%
3,627 $395,000
Q2 2020

Aug 14, 2020
BUY
$76.57 - $98.0 $8,422 - $10,780
110 Added 2.95%
3,841 $351,000
Q1 2020

May 15, 2020
SELL
$62.82 - $91.86 $12,187 - $17,820
-194 Reduced 4.94%
3,731 $294,000
Q4 2019

Feb 14, 2020
SELL
$78.51 - $87.4 $7,851 - $8,740
-100 Reduced 2.48%
3,925 $341,000
Q3 2019

Oct 29, 2019
BUY
$81.84 - $88.74 $31,672 - $34,342
387 Added 10.64%
4,025 $337,000
Q2 2019

Jul 24, 2019
BUY
$72.88 - $85.0 $3,935 - $4,590
54 Added 1.51%
3,638 $306,000
Q1 2019

May 10, 2019
SELL
$66.22 - $80.06 $5,430 - $6,564
-82 Reduced 2.24%
3,584 $287,000
Q4 2018

Feb 14, 2019
BUY
$65.56 - $74.27 $240,342 - $272,273
3,666 New
3,666 $269,000

Others Institutions Holding ABT

# of Institutions
3,161
Shares Held
1.33B
Call Options Held
8.63M
Put Options Held
7.19M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Claro Advisors LLC Portfolio

Follow Claro Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claro Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claro Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email